Oramed Pharmaceuticals (ORMP) Return on Capital Employed Growth (3y) (2015 - 2026)
Oramed Pharmaceuticals (ORMP) Return on Capital Employed Growth (3y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Oramed Pharmaceuticals |
151.47 Mn |
133.31 Mn |
- |
3,081.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
3,081.00 |
| Dec 31, 2025 |
3,511.00 |
| Sep 30, 2025 |
3,319.00 |
| Jun 30, 2025 |
2,786.00 |
| Mar 31, 2025 |
1,336.00 |
| Aug 31, 2021 |
-1,460.00 |
| Nov 30, 2019 |
4,510.00 |
| Aug 31, 2019 |
2,888.00 |
| May 31, 2019 |
-1,463.00 |
| Feb 28, 2019 |
-236.00 |
| Nov 30, 2018 |
165.00 |
| Aug 31, 2018 |
2,512.00 |
| Aug 31, 2017 |
3,977.00 |
| May 31, 2017 |
-9,995.00 |
| Feb 28, 2017 |
-7,778.00 |
| Nov 30, 2016 |
-9,818.00 |
| Aug 31, 2016 |
-10,729.00 |
| May 31, 2016 |
8,735.00 |
| Feb 29, 2016 |
4,754.00 |
| Nov 30, 2015 |
4,229.00 |
